Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Youkenafil Hydrochloride Tablets in Male Erectile Dysfunction
CTR20211201Phase 3Completed
- Sponsor
- Yangtze River Pharmaceutical Group
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of youkenafil in erectile dysfunction (ED), sponsored by Yangtze River Pharmaceutical Group. Started Jun 2021; status: completed.
02
Drugs
youkenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on CTR20211201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211201.